{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:08:24Z","timestamp":1792782504170,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"S\u00f8rlandet Sykehus HF"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuroradiology"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Many consider white matter hyperintensities (WMHs) to be important imaging findings in neuroborreliosis. However, evidence regarding association with WMHs is of low quality. The objective was to investigate WMHs in neuroborreliosis visually and quantitatively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Patients underwent brain MRI within one month of diagnosis and six months after treatment. Healthy controls were recruited. WMHs were counted by visual rating and the volume was calculated from automatic segmentation. Biochemical markers and scores for clinical symptoms and findings were used to explore association with longitudinal volume change of WMHs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The study included 74 patients (37 males) with early neuroborreliosis and 65 controls (30 males). Mean age (standard deviation) was 57.4 (13.5) and 57.7 (12.9) years, respectively. Baseline WMH lesion count was zero in 14 patients\/16 controls,\u2009&lt;\u200910 in 36\/31, 10\u201320 in 9\/7 and\u2009&gt;\u200920 in 13\/11, with no difference between groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.90). However, from baseline to follow-up the patients had a small reduction in WMH volume and the controls a small increase, median difference 0.136 (95% confidence interval 0.051\u20130.251) ml. In patients, volume change was not associated with biochemical or clinical markers, but with degree of WMHs (\n                      <jats:italic>p<\/jats:italic>\n                      values 0.002\u20130.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>WMH lesions were not more numerous in patients with neuroborreliosis compared to healthy controls. However, there was a small reduction of WMH volume from baseline to follow-up among patients, which was associated with higher baseline WMH severity, but not with disease burden or outcome. Overall, non-specific WMHs should not be considered suggestive of neuroborreliosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00234-024-03482-0","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T07:03:40Z","timestamp":1729235020000},"page":"37-48","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Are white matter hyperintensities associated with neuroborreliosis? The answer is twofold"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8900-4419","authenticated-orcid":false,"given":"Elisabeth S.","family":"Lindland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-1561","authenticated-orcid":false,"given":"Martin S.","family":"R\u00f8vang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-6287","authenticated-orcid":false,"given":"Anne Marit","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1668-5799","authenticated-orcid":false,"given":"Silje","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3221-3643","authenticated-orcid":false,"given":"Ingerid","family":"Skarstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7258-3693","authenticated-orcid":false,"given":"Nazeer","family":"Dareez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7300-2355","authenticated-orcid":false,"given":"Bradley J.","family":"MacIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0104-9626","authenticated-orcid":false,"given":"Randi","family":"Eikeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7666-1396","authenticated-orcid":false,"given":"Unn","family":"Lj\u00f8stad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-2805","authenticated-orcid":false,"given":"\u00c5se","family":"Mygland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2975-7520","authenticated-orcid":false,"given":"Steffan D.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5901-8422","authenticated-orcid":false,"given":"Elling","family":"Ulvestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4874-8707","authenticated-orcid":false,"given":"Harald","family":"Reiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6918-4157","authenticated-orcid":false,"given":"\u00c5slaug R.","family":"Lorentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6047-0122","authenticated-orcid":false,"given":"Hanne F.","family":"Harbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3486-3141","authenticated-orcid":false,"given":"Atle","family":"Bj\u00f8rnerud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9156-6357","authenticated-orcid":false,"given":"Mona K.","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,18]]},"reference":[{"key":"3482_CR1","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1093\/brain\/awac206","volume":"145","author":"JJ Halperin","year":"2022","unstructured":"Halperin JJ, Eikeland R, Branda JA, Dersch R (2022) Lyme neuroborreliosis: known knowns, known unknowns. Brain 145:2635\u20132647. https:\/\/doi.org\/10.1093\/brain\/awac206","journal-title":"Brain"},{"key":"3482_CR2","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1212\/WNL.0000000000011151","volume":"96","author":"PM Lantos","year":"2021","unstructured":"Lantos PM, Rumbaugh J, Bockenstedt LK et al (2021) Clinical practice guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 guidelines for the prevention, diagnosis, and treatment of lyme disease. Neurology 96:262\u2013273. https:\/\/doi.org\/10.1212\/WNL.0000000000011151","journal-title":"Neurology"},{"issue":"8\u201316","key":"3482_CR3","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A, Ljostad U, Fingerle V et al (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(8\u201316):e11-14. https:\/\/doi.org\/10.1111\/j.1468-1331.2009.02862.x","journal-title":"Eur J Neurol"},{"key":"3482_CR4","first-page":"892","volume":"27","author":"F Agosta","year":"2006","unstructured":"Agosta F, Rocca MA, Benedetti B, Capra R, Cordioli C, Filippi M (2006) MR imaging assessment of brain and cervical cord damage in patients with neuroborreliosis. AJNR Am J Neuroradiol 27:892\u2013894","journal-title":"AJNR Am J Neuroradiol"},{"key":"3482_CR5","first-page":"479","volume":"11","author":"RE Fernandez","year":"1990","unstructured":"Fernandez RE, Rothberg M, Ferencz G, Wujack D (1990) Lyme disease of the CNS: MR imaging findings in 14 cases. AJNR Am J Neuroradiol 11:479\u2013481","journal-title":"AJNR Am J Neuroradiol"},{"key":"3482_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1212\/WNL.39.6.753","volume":"39","author":"JJ Halperin","year":"1989","unstructured":"Halperin JJ, Luft BJ, Anand AK et al (1989) Lyme neuroborreliosis: central nervous system manifestations. Neurology 39:753\u2013759","journal-title":"Neurology"},{"key":"3482_CR7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1749-6632.1988.tb31835.x","volume":"539","author":"JJ Halperin","year":"1988","unstructured":"Halperin JJ, Pass HL, Anand AK, Luft BJ, Volkman DJ, Dattwyler RJ (1988) Nervous system abnormalities in Lyme disease. Ann N Y Acad Sci 539:24\u201334","journal-title":"Ann N Y Acad Sci"},{"key":"3482_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/BF00319739","volume":"238","author":"H Kruger","year":"1991","unstructured":"Kruger H, Heim E, Schuknecht B, Scholz S (1991) Acute and chronic neuroborreliosis with and without CNS involvement: a clinical, MRI, and HLA study of 27 cases. J Neurol 238:271\u2013280","journal-title":"J Neurol"},{"key":"3482_CR9","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1212\/WNL.49.6.1661","volume":"49","author":"EL Logigian","year":"1997","unstructured":"Logigian EL, Johnson KA, Kijewski MF et al (1997) Reversible cerebral hypoperfusion in Lyme encephalopathy. Neurology 49:1661\u20131670","journal-title":"Neurology"},{"key":"3482_CR10","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1212\/WNL.57.11.1980","volume":"57","author":"K Morgen","year":"2001","unstructured":"Morgen K, Martin R, Stone RD et al (2001) FLAIR and magnetization transfer imaging of patients with post-treatment Lyme disease syndrome. Neurology 57:1980\u20131985","journal-title":"Neurology"},{"key":"3482_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1148\/radiol.2531081103","volume":"253","author":"R Agarwal","year":"2009","unstructured":"Agarwal R, Sze G (2009) Neuro-lyme disease: MR imaging findings. Radiology 253:167\u2013173. https:\/\/doi.org\/10.1148\/radiol.2531081103","journal-title":"Radiology"},{"key":"3482_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2021.101678","volume":"12","author":"S Andreassen","year":"2021","unstructured":"Andreassen S, Lindland EMS, Solheim AM et al (2021) Cognitive function, fatigue and Fazekas score in patients with acute neuroborreliosis. Ticks Tick Borne Dis 12:101678. https:\/\/doi.org\/10.1016\/j.ttbdis.2021.101678","journal-title":"Ticks Tick Borne Dis"},{"key":"3482_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117176","volume":"419","author":"M Orbaek","year":"2020","unstructured":"Orbaek M, Bodilsen J, Gynthersen RMM et al (2020) CT and MR neuroimaging findings in patients with Lyme neuroborreliosis: a national prospective cohort study. J Neurol Sci 419:117176. https:\/\/doi.org\/10.1016\/j.jns.2020.117176","journal-title":"J Neurol Sci"},{"key":"3482_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1080\/02841850701367903","volume":"48","author":"A Aalto","year":"2007","unstructured":"Aalto A, Sjowall J, Davidsson L, Forsberg P, Smedby O (2007) Brain magnetic resonance imaging does not contribute to the diagnosis of chronic neuroborreliosis. Acta Radiol 48:755\u2013762. https:\/\/doi.org\/10.1080\/02841850701367903","journal-title":"Acta Radiol"},{"key":"3482_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0271425","volume":"17","author":"CL Marvel","year":"2022","unstructured":"Marvel CL, Alm KH, Bhattacharya D et al (2022) A multimodal neuroimaging study of brain abnormalities and clinical correlates in post treatment Lyme disease. PLoS ONE 17:e0271425. https:\/\/doi.org\/10.1371\/journal.pone.0271425","journal-title":"PLoS ONE"},{"key":"3482_CR16","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1468-1331.2007.01799.x","volume":"14","author":"U Ljostad","year":"2007","unstructured":"Ljostad U, Skarpaas T, Mygland A (2007) Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis. Eur J Neurol 14:873\u2013876. https:\/\/doi.org\/10.1111\/j.1468-1331.2007.01799.x","journal-title":"Eur J Neurol"},{"key":"3482_CR17","doi-asserted-by":"publisher","unstructured":"Andreassen S, Lindland EMS, Beyer MK et al (2022) Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis. J Neurol.\u00a0https:\/\/doi.org\/10.1007\/s00415-022-11463-7","DOI":"10.1007\/s00415-022-11463-7"},{"key":"3482_CR18","doi-asserted-by":"publisher","unstructured":"Andreassen S, Solheim AM, Ljostad U et al (2022) Cognitive function in patients with neuroborreliosis: a prospective cohort study from the acute phase to 12 months post treatment. Brain Behav 12:e2608.\u00a0https:\/\/doi.org\/10.1002\/brb3.2608","DOI":"10.1002\/brb3.2608"},{"key":"3482_CR19","doi-asserted-by":"publisher","unstructured":"Lindland ES, Solheim AM, Andreassen S et al (2023) Dynamic contrast-enhanced MRI shows altered blood-brain barrier function of deep gray matter structures in neuroborreliosis: a case-control study. Eur Radiol Exp 7:52.\u00a0https:\/\/doi.org\/10.1186\/s41747-023-00365-6","DOI":"10.1186\/s41747-023-00365-6"},{"key":"3482_CR20","doi-asserted-by":"publisher","unstructured":"Lindland ES, Solheim AM, Dareez MN et al (2022) Enhancement of cranial nerves in Lyme neuroborreliosis: incidence and correlation with clinical symptoms and prognosis. Neuroradiology 64:2323\u20132333.\u00a0https:\/\/doi.org\/10.1007\/s00234-022-02957-2","DOI":"10.1007\/s00234-022-02957-2"},{"key":"3482_CR21","doi-asserted-by":"publisher","unstructured":"Solheim AM, Ljostad U, Mygland A (2019) Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial. BMJ Open 9:e027083.\u00a0https:\/\/doi.org\/10.1136\/bmjopen-2018-027083","DOI":"10.1136\/bmjopen-2018-027083"},{"key":"3482_CR22","doi-asserted-by":"publisher","unstructured":"Solheim AM, Lorentzen AR, Dahlberg AO et al (2022) Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial. J Neurol Neurosurg Psychiatry 93:1222\u20131228.\u00a0https:\/\/doi.org\/10.1136\/jnnp-2022-329724","DOI":"10.1136\/jnnp-2022-329724"},{"key":"3482_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol 149:351\u2013356. https:\/\/doi.org\/10.2214\/ajr.149.2.351","journal-title":"AJR Am J Roentgenol"},{"key":"3482_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285683","volume":"18","author":"MS Rovang","year":"2023","unstructured":"Rovang MS, Selnes P, MacIntosh BJ et al (2023) Segmenting white matter hyperintensities on isotropic three-dimensional fluid attenuated inversion recovery magnetic resonance images: assessing deep learning tools on a Norwegian imaging database. PLoS ONE 18:e0285683. https:\/\/doi.org\/10.1371\/journal.pone.0285683","journal-title":"PLoS ONE"},{"key":"3482_CR25","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.neuroimage.2006.01.015","volume":"31","author":"PA Yushkevich","year":"2006","unstructured":"Yushkevich PA, Piven J, Hazlett HC et al (2006) User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage 31:1116\u20131128. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.01.015","journal-title":"Neuroimage"},{"key":"3482_CR26","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121\u20131123. https:\/\/doi.org\/10.1001\/archneur.1989.00520460115022","journal-title":"Arch Neurol"},{"key":"3482_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012","journal-title":"J Chiropr Med"},{"key":"3482_CR28","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2307\/1932409","volume":"26","author":"LR Dice","year":"1945","unstructured":"Dice LR (1945) Measures of the amount of ecologic association between species. Egcology 26:297\u2013302","journal-title":"Egcology"},{"key":"3482_CR29","doi-asserted-by":"publisher","first-page":"e2454","DOI":"10.1212\/WNL.0000000000201205","volume":"99","author":"ACC Jochems","year":"2022","unstructured":"Jochems ACC, Arteaga C, Chappell F et al (2022) Longitudinal changes of white matter hyperintensities in sporadic small vessel disease: a systematic review and meta-analysis. Neurology 99:e2454\u2013e2463. https:\/\/doi.org\/10.1212\/WNL.0000000000201205","journal-title":"Neurology"},{"key":"3482_CR30","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41467-020-14612-6","volume":"11","author":"M Khalil","year":"2020","unstructured":"Khalil M, Pirpamer L, Hofer E et al (2020) Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat Commun 11:812. https:\/\/doi.org\/10.1038\/s41467-020-14612-6","journal-title":"Nat Commun"},{"key":"3482_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"J Landis","year":"1977","unstructured":"Landis J, Koch G (1977) The measurement of observer agreement for categorical data. Biometrics 33:159\u2013174","journal-title":"Biometrics"},{"key":"3482_CR32","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/jnnp-2021-326569","volume":"92","author":"R Brown","year":"2021","unstructured":"Brown R, Low A, Markus HS (2021) Rate of, and risk factors for, white matter hyperintensity growth: a systematic review and meta-analysis with implications for clinical trial design. J Neurol Neurosurg Psychiatry 92:1271\u20131277. https:\/\/doi.org\/10.1136\/jnnp-2021-326569","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3482_CR33","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1212\/WNL.0000000000004490","volume":"89","author":"EMC van Leijsen","year":"2017","unstructured":"van Leijsen EMC, van Uden IWM, Ghafoorian M et al (2017) Nonlinear temporal dynamics of cerebral small vessel disease: the RUN DMC study. Neurology 89:1569\u20131577. https:\/\/doi.org\/10.1212\/WNL.0000000000004490","journal-title":"Neurology"},{"key":"3482_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1212\/WNL.0000000000006252","volume":"91","author":"I Beuchat","year":"2018","unstructured":"Beuchat I, Dunet V, Meylan P, Du Pasquier R (2018) Late Lyme neuroborreliosis with chronic encephalomyelitis. Neurology 91:627\u2013628. https:\/\/doi.org\/10.1212\/WNL.0000000000006252","journal-title":"Neurology"},{"key":"3482_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s42466-022-00167-y","volume":"4","author":"DK Erhart","year":"2022","unstructured":"Erhart DK, Bracknies V, Lutz-Schuhbauer S, Wigand S, Tumani H (2022) The special role of CXCL13 in Lyme neuroborreliosis: a case report. Neurol Res Pract 4:3. https:\/\/doi.org\/10.1186\/s42466-022-00167-y","journal-title":"Neurol Res Pract"},{"key":"3482_CR36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1212\/WNL.0b013e3181af78cc","volume":"73","author":"A Haene","year":"2009","unstructured":"Haene A, Troger M (2009) Diffuse hyperintense brainstem lesions in neuroborreliosis. Neurology 73:326. https:\/\/doi.org\/10.1212\/WNL.0b013e3181af78cc","journal-title":"Neurology"},{"key":"3482_CR37","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00234-005-1440-2","volume":"47","author":"P Kalina","year":"2005","unstructured":"Kalina P, Decker A, Kornel E, Halperin JJ (2005) Lyme disease of the brainstem. Neuroradiology 47:903\u2013907. https:\/\/doi.org\/10.1007\/s00234-005-1440-2","journal-title":"Neuroradiology"},{"key":"3482_CR38","doi-asserted-by":"publisher","unstructured":"Kashyap M, Kashyap PV (2023) Neuroborreliosis: unusual clinical presentation and imaging features. J Neurosci Rural Pract 14:132\u2013136. https:\/\/doi.org\/10.25259\/JNRP-2022-7-4","DOI":"10.25259\/JNRP-2022-7-4"},{"key":"3482_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00415-020-10188-9","volume":"268","author":"T Pfefferkorn","year":"2021","unstructured":"Pfefferkorn T, Rother J, Eckert B, Janssen H (2021) Brainstem encephalitis in neuroborreliosis: typical clinical course and distinct MRI findings. J Neurol 268:502\u2013505. https:\/\/doi.org\/10.1007\/s00415-020-10188-9","journal-title":"J Neurol"},{"key":"3482_CR40","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1212\/WNL.0000000000002913","volume":"87","author":"E Pruvost-Robieux","year":"2016","unstructured":"Pruvost-Robieux E, Yeung J, Sudacevschi V, Cordoliani Y, De Malherbe M, Pico F (2016) Reversible corticospinal tract hyperintensities in neurologic Lyme disease. Neurology 87:548\u2013549. https:\/\/doi.org\/10.1212\/WNL.0000000000002913","journal-title":"Neurology"},{"key":"3482_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2023.e01704","volume":"31","author":"SB Rosendahl","year":"2023","unstructured":"Rosendahl SB, Ravn P, Lebech AM, Midtgaard Stenor CP (2023) Lyme neuroborreliosis with encephalitis: a rare case. IDCases 31:e01704. https:\/\/doi.org\/10.1016\/j.idcr.2023.e01704","journal-title":"IDCases"},{"key":"3482_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2022.e01472","volume":"28","author":"H Svingen","year":"2022","unstructured":"Svingen H, Orrem J, Norgaard Eskesen A (2022) Neuroborreliosis with involvement of rhombencephalon: a case report. IDCases 28:e01472. https:\/\/doi.org\/10.1016\/j.idcr.2022.e01472","journal-title":"IDCases"},{"key":"3482_CR43","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.4081\/idr.2014.5496","volume":"6","author":"V Verma","year":"2014","unstructured":"Verma V, Roman M, Shah D, Zaretskaya M, Yassin MH (2014) A case of chronic progressive lyme encephalitis as a manifestation of late lyme neuroborreliosis. Infect Dis Rep 6:5496. https:\/\/doi.org\/10.4081\/idr.2014.5496","journal-title":"Infect Dis Rep"},{"key":"3482_CR44","doi-asserted-by":"publisher","first-page":"12486","DOI":"10.1038\/s41598-024-63006-x","volume":"14","author":"T Volk","year":"2024","unstructured":"Volk T, Urbach H, Fingerle V, Bardutzky J, Rauer S, Dersch R (2024) Spectrum of MRI findings in central nervous system affection in Lyme neuroborreliosis. Sci Rep 14:12486. https:\/\/doi.org\/10.1038\/s41598-024-63006-x","journal-title":"Sci Rep"},{"key":"3482_CR45","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s13244-018-0646-x","volume":"9","author":"ES Lindland","year":"2018","unstructured":"Lindland ES, Solheim AM, Andreassen S et al (2018) Imaging in Lyme neuroborreliosis. Insights. Imaging 9:833\u2013844. https:\/\/doi.org\/10.1007\/s13244-018-0646-x","journal-title":"Imaging"},{"key":"3482_CR46","doi-asserted-by":"publisher","unstructured":"Raffetin A, Schemoul J, Chahour A et al (2022) Multidisciplinary management of suspected Lyme Borreliosis: clinical features of 569 patients, and factors associated with recovery at 3 and 12 months, a prospective Cohort study. Microorganisms 10. https:\/\/doi.org\/10.3390\/microorganisms10030607","DOI":"10.3390\/microorganisms10030607"},{"key":"3482_CR47","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1017\/cjn.2020.129","volume":"47","author":"G MacLean","year":"2020","unstructured":"MacLean G, Cook P, Lindsay LR, Hatchette TF, Webster D (2020) Low Seroprevalence of Lyme disease among multiple sclerosis patients in New Brunswick. Can J Neurol Sci 47:842\u2013844. https:\/\/doi.org\/10.1017\/cjn.2020.129","journal-title":"Can J Neurol Sci"},{"key":"3482_CR48","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/jnnp.51.9.1215","volume":"51","author":"E Schmutzhard","year":"1988","unstructured":"Schmutzhard E, Pohl P, Stanek G (1988) Borrelia burgdorferi antibodies in patients with relapsing\/remitting form and chronic progressive form of multiple sclerosis. J Neurol Neurosurg Psychiatry 51:1215\u20131218. https:\/\/doi.org\/10.1136\/jnnp.51.9.1215","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3482_CR49","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1600-0404.2010.01411.x","volume":"123","author":"A Vatne","year":"2011","unstructured":"Vatne A, Mygland A, Ljostad U (2011) Multiple sclerosis in Vest-Agder County, Norway. Acta Neurol Scand 123:396\u2013399. https:\/\/doi.org\/10.1111\/j.1600-0404.2010.01411.x","journal-title":"Acta Neurol Scand"},{"key":"3482_CR50","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1177\/1352458508096878","volume":"14","author":"DH Miller","year":"2008","unstructured":"Miller DH, Weinshenker BG, Filippi M et al (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14:1157\u20131174. https:\/\/doi.org\/10.1177\/1352458508096878","journal-title":"Mult Scler"},{"key":"3482_CR51","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/jmri.27479","volume":"53","author":"L Melazzini","year":"2021","unstructured":"Melazzini L, Vitali P, Olivieri E et al (2021) White matter hyperintensities quantification in healthy adults: a systematic review and meta-analysis. J Magn Reson Imaging 53:1732\u20131743. https:\/\/doi.org\/10.1002\/jmri.27479","journal-title":"J Magn Reson Imaging"},{"key":"3482_CR52","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ et al (2013) Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 12:822\u2013838. https:\/\/doi.org\/10.1016\/S1474-4422(13)70124-8","journal-title":"Lancet Neurol"},{"key":"3482_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/jnen\/nlac103","volume":"82","author":"D Lahna","year":"2022","unstructured":"Lahna D, Roese N, Woltjer R et al (2022) Postmortem 7T MRI for guided histopathology and evaluation of cerebrovascular disease. J Neuropathol Exp Neurol 82:57\u201370. https:\/\/doi.org\/10.1093\/jnen\/nlac103","journal-title":"J Neuropathol Exp Neurol"},{"key":"3482_CR54","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001140","volume":"4","author":"JM Wardlaw","year":"2015","unstructured":"Wardlaw JM, Valdes Hernandez MC, Munoz-Maniega S (2015) What are white matter hyperintensities made of? Relevance to vascular cognitive impairment. J Am Heart Assoc 4:001140. https:\/\/doi.org\/10.1161\/JAHA.114.001140","journal-title":"J Am Heart Assoc"},{"key":"3482_CR55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fnagi.2016.00062","volume":"8","author":"J Ramirez","year":"2016","unstructured":"Ramirez J, McNeely AA, Berezuk C, Gao F, Black SE (2016) Dynamic progression of white matter hyperintensities in Alzheimer\u2019s disease and normal aging: results from the Sunnybrook dementia study. Front Aging Neurosci 8:62. https:\/\/doi.org\/10.3389\/fnagi.2016.00062","journal-title":"Front Aging Neurosci"},{"key":"3482_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1212\/WNL.0000000000008880","volume":"94","author":"N Yassi","year":"2020","unstructured":"Yassi N, Flicker L, Campbell BCV (2020) Brain frailty and small vessel disease for stroke outcome prediction: are we there yet? Neurology 94:191\u2013192. https:\/\/doi.org\/10.1212\/WNL.0000000000008880","journal-title":"Neurology"},{"key":"3482_CR57","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","volume":"16","author":"Y Stern","year":"2020","unstructured":"Stern Y, Arenaza-Urquijo EM, Bartres-Faz D et al (2020) Whitepaper: defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement 16:1305\u20131311. https:\/\/doi.org\/10.1016\/j.jalz.2018.07.219","journal-title":"Alzheimers Dement"},{"key":"3482_CR58","doi-asserted-by":"publisher","first-page":"117957352210981","DOI":"10.1177\/11795735221098126","volume":"14","author":"H Mens","year":"2022","unstructured":"Mens H, Fjordside L, Gynthersen RMM et al (2022) Neurofilament light in cerebrospinal fluid is associated with disease staging in European Lyme neuroborreliosis. J Cent Nerv Syst Dis 14:11795735221098126. https:\/\/doi.org\/10.1177\/11795735221098126","journal-title":"J Cent Nerv Syst Dis"},{"key":"3482_CR59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2215-0366(20)30431-4","volume":"8","author":"U Clancy","year":"2021","unstructured":"Clancy U, Gilmartin D, Jochems ACC, Knox L, Doubal FN, Wardlaw JM (2021) Neuropsychiatric symptoms associated with cerebral small vessel disease: a systematic review and meta-analysis. Lancet Psychiatry 8:225\u2013236. https:\/\/doi.org\/10.1016\/S2215-0366(20)30431-4","journal-title":"Lancet Psychiatry"},{"key":"3482_CR60","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/ane.13263","volume":"142","author":"ET Thortveit","year":"2020","unstructured":"Thortveit ET, Aase A, Petersen LB, Lorentzen AR, Mygland A, Ljostad U (2020) Subjective health complaints and exposure to tick-borne infections in southern Norway. Acta Neurol Scand 142:260\u2013266. https:\/\/doi.org\/10.1111\/ane.13263","journal-title":"Acta Neurol Scand"},{"key":"3482_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.117242","volume":"223","author":"J Wrobel","year":"2020","unstructured":"Wrobel J, Martin ML, Bakshi R et al (2020) Intensity warping for multisite MRI harmonization. Neuroimage 223:117242. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.117242","journal-title":"Neuroimage"}],"container-title":["Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-024-03482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00234-024-03482-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00234-024-03482-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T05:34:29Z","timestamp":1738820069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00234-024-03482-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,18]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3482"],"URL":"https:\/\/doi.org\/10.1007\/s00234-024-03482-0","relation":{},"ISSN":["0028-3940","1432-1920"],"issn-type":[{"value":"0028-3940","type":"print"},{"value":"1432-1920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,18]]},"assertion":[{"value":"6 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the regional ethical committee and data protection service (South-Eastern Norway Health Authority 2015\/1588), and was performed in line with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Participants gave written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Mona K. Beyer received minor grants or speaker\u00b4s fees from Biogen Idec, Merck and Novartis. Hanne F. Harbo received minor grants or speaker\u00b4s fees from Biogen, Sanofi Genzyme, Teva and Merck. \u00c5slaug R. Lorentzen received minor grant from Sanofi. The other authors do not report any disclosures.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}